Valuation: Abbott Laboratories

Market Cap 198B 169B 158B 145B 272B 18,898B 277B 1,872B 730B 9,471B 742B 725B 31,355B P/E 2026 *
32.7x
P/E 2027 * 25.2x
Enterprise Value 221B 190B 177B 162B 305B 21,189B 311B 2,099B 818B 10,619B 831B 813B 35,156B EV / Sales 2026 *
4.4x
EV / Sales 2027 * 4x
Free-Float
86.16%
Yield 2026 *
2.25%
Yield 2027 * 2.4%
1 day-0.25%
1 week+2.58%
Current month+7.98%
1 month+12.28%
3 months+29.15%
6 months+1.72%
Current year-8.90%
1 week 109.35
Extreme 109.35
115.67
1 month 99.84
Extreme 99.84
115.67
Current year 81.97
Extreme 81.97
129.46
1 year 81.97
Extreme 81.97
137.49
3 years 81.97
Extreme 81.97
141.23
5 years 81.97
Extreme 81.97
142.6
10 years 37.38
Extreme 37.38
142.6
Manager TitleAgeSince
Chief Executive Officer 52 31/03/2020
Director of Finance/CFO 53 01/09/2023
Chief Investment Officer 51 -
Director TitleAgeSince
Director/Board Member 64 09/12/2011
Director/Board Member 67 09/12/2011
Director/Board Member 71 16/02/2017
Date Insider Type Main position Quantity % Market Cap.
12/8/26 Other

EXECUTIVE VICE PRESIDENT

-12 0.0000%
30/6/26 Free

Director

416 0.0000%
30/6/26 Free

Director

432 0.0000%
Change 5-day change 1-year change 3-year change Capi.($)
-0.25%+2.58%-13.82%+10.06% 198B
-1.94%+1.90%-0.99%+13.22% 120B
-0.76%+1.51%+3.62%+74.44% 60.51B
-1.82%-6.98%+28.29%+57.62% 53.64B
+0.01%+3.10%-5.81%-31.45% 51.1B
+0.38%-1.38%+10.47%-14.93% 33.92B
-3.92%-8.43% - - 29.75B
+0.28%+2.20%+43.59%-8.77% 24.83B
-0.49%-0.14%-5.53%+5.30% 23.1B
-1.16%-4.71%-7.05%+23.65% 23.01B
Average -0.97%-0.55%+5.86%+14.35% 61.83B
Weighted average by Cap. -0.91%+0.83%-0.46%+16.17%

Financials

2026 *2027 *
Net sales 50.3B 43.07B 40.18B 36.87B 69.29B 4,813B 70.65B 477B 186B 2,412B 189B 185B 7,986B 54.65B 46.79B 43.65B 40.06B 75.27B 5,229B 76.75B 518B 202B 2,620B 205B 201B 8,676B
Net income 6.23B 5.34B 4.98B 4.57B 8.58B 596B 8.75B 59.06B 23.02B 299B 23.4B 22.89B 989B 7.92B 6.78B 6.33B 5.81B 10.92B 758B 11.13B 75.1B 29.28B 380B 29.75B 29.11B 1,258B
Net Debt 23.94B 20.5B 19.12B 17.55B 32.97B 2,291B 33.62B 227B 88.44B 1,148B 89.89B 87.93B 3,800B 20.96B 17.94B 16.74B 15.36B 28.87B 2,005B 29.43B 199B 77.42B 1,005B 78.69B 76.98B 3,327B
Logo Abbott Laboratories
Abbott Laboratories specializes in the research, development, manufacturing and marketing of pharmaceutical and medical products. Net sales break down by family of products as follows: - vascular devices (48.3%): endoprosthetic systems, dilation catheters, arterial closures, etc.; - diagnostic systems and instruments (20.2%); - nutrition products (19.1%): pediatric nutrition products, nutritional supplements, and dietetic products; - medicine (12.4%): anesthetics, antiviral products, antibiotics, inhibitors, anti-inflammatories, etc. Net sales are distributed geographically as follows: the United States (38.7%), Germany (6.2%), China (4.3%), India (4.2%), Switzerland (4.2%), Japan (3.3%), the United Kingdom (3%) and others (36.1%).
Employees
115,000
Date Price Change Volume
20/08/26 US$114.14 -0.25% 5,785,034
19/08/26 US$114.43 +1.55% 7,403,620
18/08/26 US$112.68 +2.09% 9,781,753
17/08/26 US$110.37 -0.79% 11,462,155
14/08/26 US$111.25 -0.02% 5,575,671
Trader
Investor
Global
Quality
ESG MSCI
BBB
Sell
Consensus
Buy
Mean consensus
BUY
Number of Analysts
27
Last Close Price
114.14USD
Average target price
119.40USD
Spread / Average Target
+4.61%

Quarterly revenue - Rate of surprise